Nuveen

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,886
Total Value
326452872908
Accession Number
0000930413-25-001717
Form Type
13F-HR
Manager Name
Nuveen
Data Enrichment
97% identified
8,625 identified261 unidentified

Holdings

8,886 positions • $326.5B total value
Manager:
Search and click to pin securities to the top
Page 114 of 164
Zymeworks Inc.
Shares:198.8K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
TOMPKINS FINANCIAL CORP
Shares:37.5K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
Informatica Inc.
Shares:135.5K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
Vital Energy, Inc.
Shares:111.3K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
MIMEDX GROUP, INC.
Shares:309.9K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
SCANSOURCE, INC.
Shares:69.2K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
INGLES MARKETS INC
Shares:36.2K
Value:$2.4M
% of Portfolio:0.0% ($2.4M/$326.5B)
YORK WATER CO
Shares:67.7K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
TFS Financial CORP
Shares:189.0K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Ibotta, Inc.
Shares:55.5K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Dyne Therapeutics, Inc.
Shares:223.2K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Liberty Latin America Ltd.
Shares:374.7K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Gentherm Inc
Shares:86.9K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Vir Biotechnology, Inc.
Shares:358.6K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
ENCORE CAPITAL GROUP INC
Shares:67.7K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Embecta Corp.
Shares:181.5K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
FIRST MAJESTIC SILVER CORP
Shares:345.6K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
PureCycle Technologies, Inc.
Shares:333.2K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
MESA LABORATORIES INC /CO/
Shares:19.4K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)
Madison Square Garden Entertainment Corp.
Shares:70.3K
Value:$2.3M
% of Portfolio:0.0% ($2.3M/$326.5B)